Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 4 papers. Top paper: “Randomized phase II trial of dabrafenib and trametinib with or without navitoclax in patients (pts) with BRAF-mutant (MT) metastatic melanoma (MM) (CTEP P9466).”.
Janice M. Mehnert, Anita Giobbie‐Hurder, Kari Kendra, Gino K. In, April K.S. Salama +14 more
Jason N. Sterrenberg, A Al Garawi, Vyanka Mezcord, Melissa L. Folkerts, S. Calderón +13 more
Naomie Devico Marciano, Deepika Nathan, Wen‐Pin Chen, Christine E. McLaren, Kathryn Osann +7 more
Shohei Burns, Wen‐Pin Chen, Hanna K. Mandl, C. Rosso, Niloofar Radgoudarzi +11 more